The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Overactive Bladder Non-Pharmacological Treatment Market Research Report 2025

Global Overactive Bladder Non-Pharmacological Treatment Market Research Report 2025

Publishing Date : Apr, 2025

License Type :
 

Report Code : 2010168

No of Pages : 91

Ask Your Query
Synopsis
The global market for Overactive Bladder Non-Pharmacological Treatment was valued at US$ 1500 million in the year 2024 and is projected to reach a revised size of US$ 2248 million by 2031, growing at a CAGR of 5.9% during the forecast period.
Overactive bladder non-pharmacological treatment refers to a series of treatment methods that do not rely on medication and improve patients' symptoms through behavioral adjustments, physical training, neural regulation, and other technical interventions. Overactive bladder is a syndrome characterized by urgency to urinate, often accompanied by frequent urination and nocturia symptoms. It may or may not be accompanied by urgency urinary incontinence, and can be manifested as detrusor overactivity or other forms of urethral bladder dysfunction in urodynamics, without a clear cause. The core goal of non pharmacological treatment is to restore the normal urine storage function of the bladder, enhance the patient's ability to control urination, and thus improve their quality of life.
North American market for Overactive Bladder Non-Pharmacological Treatment is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Overactive Bladder Non-Pharmacological Treatment is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Overactive Bladder Non-Pharmacological Treatment in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Overactive Bladder Non-Pharmacological Treatment include Medtronic, Axonics Modulation Technologies, Cogentix Medica, Laborie Medical Technologies, Avation Medical, Bioness, Boston Scientific, Allergan, Abbvie, Mindray, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Overactive Bladder Non-Pharmacological Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Overactive Bladder Non-Pharmacological Treatment.
The Overactive Bladder Non-Pharmacological Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Overactive Bladder Non-Pharmacological Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Overactive Bladder Non-Pharmacological Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Medtronic
Axonics Modulation Technologies
Cogentix Medica
Laborie Medical Technologies
Avation Medical
Bioness
Boston Scientific
Allergan
Abbvie
Mindray
APT Medical
Vishee
Beijing Easymonitor Technology
NCC Medical
Hangzhou General Stim Biotechnology
Jiangsu Hengrui Pharmaceuticals
Segment by Type
Behavior Therapy
Physical Training
Neuromodulation Methods
Others
Segment by Application
Hospital
Clinic
Rehabilitation Institutions
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Overactive Bladder Non-Pharmacological Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Overactive Bladder Non-Pharmacological Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Behavior Therapy
1.2.3 Physical Training
1.2.4 Neuromodulation Methods
1.2.5 Others
1.3 Market by Application
1.3.1 Global Overactive Bladder Non-Pharmacological Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Rehabilitation Institutions
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Overactive Bladder Non-Pharmacological Treatment Market Perspective (2020-2031)
2.2 Global Overactive Bladder Non-Pharmacological Treatment Growth Trends by Region
2.2.1 Global Overactive Bladder Non-Pharmacological Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Overactive Bladder Non-Pharmacological Treatment Historic Market Size by Region (2020-2025)
2.2.3 Overactive Bladder Non-Pharmacological Treatment Forecasted Market Size by Region (2026-2031)
2.3 Overactive Bladder Non-Pharmacological Treatment Market Dynamics
2.3.1 Overactive Bladder Non-Pharmacological Treatment Industry Trends
2.3.2 Overactive Bladder Non-Pharmacological Treatment Market Drivers
2.3.3 Overactive Bladder Non-Pharmacological Treatment Market Challenges
2.3.4 Overactive Bladder Non-Pharmacological Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Overactive Bladder Non-Pharmacological Treatment Players by Revenue
3.1.1 Global Top Overactive Bladder Non-Pharmacological Treatment Players by Revenue (2020-2025)
3.1.2 Global Overactive Bladder Non-Pharmacological Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Top Overactive Bladder Non-Pharmacological Treatment Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Overactive Bladder Non-Pharmacological Treatment Revenue
3.4 Global Overactive Bladder Non-Pharmacological Treatment Market Concentration Ratio
3.4.1 Global Overactive Bladder Non-Pharmacological Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Overactive Bladder Non-Pharmacological Treatment Revenue in 2024
3.5 Global Key Players of Overactive Bladder Non-Pharmacological Treatment Head office and Area Served
3.6 Global Key Players of Overactive Bladder Non-Pharmacological Treatment, Product and Application
3.7 Global Key Players of Overactive Bladder Non-Pharmacological Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Overactive Bladder Non-Pharmacological Treatment Breakdown Data by Type
4.1 Global Overactive Bladder Non-Pharmacological Treatment Historic Market Size by Type (2020-2025)
4.2 Global Overactive Bladder Non-Pharmacological Treatment Forecasted Market Size by Type (2026-2031)
5 Overactive Bladder Non-Pharmacological Treatment Breakdown Data by Application
5.1 Global Overactive Bladder Non-Pharmacological Treatment Historic Market Size by Application (2020-2025)
5.2 Global Overactive Bladder Non-Pharmacological Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Overactive Bladder Non-Pharmacological Treatment Market Size (2020-2031)
6.2 North America Overactive Bladder Non-Pharmacological Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Overactive Bladder Non-Pharmacological Treatment Market Size by Country (2020-2025)
6.4 North America Overactive Bladder Non-Pharmacological Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Overactive Bladder Non-Pharmacological Treatment Market Size (2020-2031)
7.2 Europe Overactive Bladder Non-Pharmacological Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Overactive Bladder Non-Pharmacological Treatment Market Size by Country (2020-2025)
7.4 Europe Overactive Bladder Non-Pharmacological Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Overactive Bladder Non-Pharmacological Treatment Market Size (2020-2031)
8.2 Asia-Pacific Overactive Bladder Non-Pharmacological Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Overactive Bladder Non-Pharmacological Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Overactive Bladder Non-Pharmacological Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Overactive Bladder Non-Pharmacological Treatment Market Size (2020-2031)
9.2 Latin America Overactive Bladder Non-Pharmacological Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Overactive Bladder Non-Pharmacological Treatment Market Size by Country (2020-2025)
9.4 Latin America Overactive Bladder Non-Pharmacological Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Overactive Bladder Non-Pharmacological Treatment Market Size (2020-2031)
10.2 Middle East & Africa Overactive Bladder Non-Pharmacological Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Overactive Bladder Non-Pharmacological Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Overactive Bladder Non-Pharmacological Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Medtronic
11.1.1 Medtronic Company Details
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Overactive Bladder Non-Pharmacological Treatment Introduction
11.1.4 Medtronic Revenue in Overactive Bladder Non-Pharmacological Treatment Business (2020-2025)
11.1.5 Medtronic Recent Development
11.2 Axonics Modulation Technologies
11.2.1 Axonics Modulation Technologies Company Details
11.2.2 Axonics Modulation Technologies Business Overview
11.2.3 Axonics Modulation Technologies Overactive Bladder Non-Pharmacological Treatment Introduction
11.2.4 Axonics Modulation Technologies Revenue in Overactive Bladder Non-Pharmacological Treatment Business (2020-2025)
11.2.5 Axonics Modulation Technologies Recent Development
11.3 Cogentix Medica
11.3.1 Cogentix Medica Company Details
11.3.2 Cogentix Medica Business Overview
11.3.3 Cogentix Medica Overactive Bladder Non-Pharmacological Treatment Introduction
11.3.4 Cogentix Medica Revenue in Overactive Bladder Non-Pharmacological Treatment Business (2020-2025)
11.3.5 Cogentix Medica Recent Development
11.4 Laborie Medical Technologies
11.4.1 Laborie Medical Technologies Company Details
11.4.2 Laborie Medical Technologies Business Overview
11.4.3 Laborie Medical Technologies Overactive Bladder Non-Pharmacological Treatment Introduction
11.4.4 Laborie Medical Technologies Revenue in Overactive Bladder Non-Pharmacological Treatment Business (2020-2025)
11.4.5 Laborie Medical Technologies Recent Development
11.5 Avation Medical
11.5.1 Avation Medical Company Details
11.5.2 Avation Medical Business Overview
11.5.3 Avation Medical Overactive Bladder Non-Pharmacological Treatment Introduction
11.5.4 Avation Medical Revenue in Overactive Bladder Non-Pharmacological Treatment Business (2020-2025)
11.5.5 Avation Medical Recent Development
11.6 Bioness
11.6.1 Bioness Company Details
11.6.2 Bioness Business Overview
11.6.3 Bioness Overactive Bladder Non-Pharmacological Treatment Introduction
11.6.4 Bioness Revenue in Overactive Bladder Non-Pharmacological Treatment Business (2020-2025)
11.6.5 Bioness Recent Development
11.7 Boston Scientific
11.7.1 Boston Scientific Company Details
11.7.2 Boston Scientific Business Overview
11.7.3 Boston Scientific Overactive Bladder Non-Pharmacological Treatment Introduction
11.7.4 Boston Scientific Revenue in Overactive Bladder Non-Pharmacological Treatment Business (2020-2025)
11.7.5 Boston Scientific Recent Development
11.8 Allergan
11.8.1 Allergan Company Details
11.8.2 Allergan Business Overview
11.8.3 Allergan Overactive Bladder Non-Pharmacological Treatment Introduction
11.8.4 Allergan Revenue in Overactive Bladder Non-Pharmacological Treatment Business (2020-2025)
11.8.5 Allergan Recent Development
11.9 Abbvie
11.9.1 Abbvie Company Details
11.9.2 Abbvie Business Overview
11.9.3 Abbvie Overactive Bladder Non-Pharmacological Treatment Introduction
11.9.4 Abbvie Revenue in Overactive Bladder Non-Pharmacological Treatment Business (2020-2025)
11.9.5 Abbvie Recent Development
11.10 Mindray
11.10.1 Mindray Company Details
11.10.2 Mindray Business Overview
11.10.3 Mindray Overactive Bladder Non-Pharmacological Treatment Introduction
11.10.4 Mindray Revenue in Overactive Bladder Non-Pharmacological Treatment Business (2020-2025)
11.10.5 Mindray Recent Development
11.11 APT Medical
11.11.1 APT Medical Company Details
11.11.2 APT Medical Business Overview
11.11.3 APT Medical Overactive Bladder Non-Pharmacological Treatment Introduction
11.11.4 APT Medical Revenue in Overactive Bladder Non-Pharmacological Treatment Business (2020-2025)
11.11.5 APT Medical Recent Development
11.12 Vishee
11.12.1 Vishee Company Details
11.12.2 Vishee Business Overview
11.12.3 Vishee Overactive Bladder Non-Pharmacological Treatment Introduction
11.12.4 Vishee Revenue in Overactive Bladder Non-Pharmacological Treatment Business (2020-2025)
11.12.5 Vishee Recent Development
11.13 Beijing Easymonitor Technology
11.13.1 Beijing Easymonitor Technology Company Details
11.13.2 Beijing Easymonitor Technology Business Overview
11.13.3 Beijing Easymonitor Technology Overactive Bladder Non-Pharmacological Treatment Introduction
11.13.4 Beijing Easymonitor Technology Revenue in Overactive Bladder Non-Pharmacological Treatment Business (2020-2025)
11.13.5 Beijing Easymonitor Technology Recent Development
11.14 NCC Medical
11.14.1 NCC Medical Company Details
11.14.2 NCC Medical Business Overview
11.14.3 NCC Medical Overactive Bladder Non-Pharmacological Treatment Introduction
11.14.4 NCC Medical Revenue in Overactive Bladder Non-Pharmacological Treatment Business (2020-2025)
11.14.5 NCC Medical Recent Development
11.15 Hangzhou General Stim Biotechnology
11.15.1 Hangzhou General Stim Biotechnology Company Details
11.15.2 Hangzhou General Stim Biotechnology Business Overview
11.15.3 Hangzhou General Stim Biotechnology Overactive Bladder Non-Pharmacological Treatment Introduction
11.15.4 Hangzhou General Stim Biotechnology Revenue in Overactive Bladder Non-Pharmacological Treatment Business (2020-2025)
11.15.5 Hangzhou General Stim Biotechnology Recent Development
11.16 Jiangsu Hengrui Pharmaceuticals
11.16.1 Jiangsu Hengrui Pharmaceuticals Company Details
11.16.2 Jiangsu Hengrui Pharmaceuticals Business Overview
11.16.3 Jiangsu Hengrui Pharmaceuticals Overactive Bladder Non-Pharmacological Treatment Introduction
11.16.4 Jiangsu Hengrui Pharmaceuticals Revenue in Overactive Bladder Non-Pharmacological Treatment Business (2020-2025)
11.16.5 Jiangsu Hengrui Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
List of Tables
Table 1. Global Overactive Bladder Non-Pharmacological Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Behavior Therapy
Table 3. Key Players of Physical Training
Table 4. Key Players of Neuromodulation Methods
Table 5. Key Players of Others
Table 6. Global Overactive Bladder Non-Pharmacological Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Overactive Bladder Non-Pharmacological Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Overactive Bladder Non-Pharmacological Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Overactive Bladder Non-Pharmacological Treatment Market Share by Region (2020-2025)
Table 10. Global Overactive Bladder Non-Pharmacological Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Overactive Bladder Non-Pharmacological Treatment Market Share by Region (2026-2031)
Table 12. Overactive Bladder Non-Pharmacological Treatment Market Trends
Table 13. Overactive Bladder Non-Pharmacological Treatment Market Drivers
Table 14. Overactive Bladder Non-Pharmacological Treatment Market Challenges
Table 15. Overactive Bladder Non-Pharmacological Treatment Market Restraints
Table 16. Global Overactive Bladder Non-Pharmacological Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Overactive Bladder Non-Pharmacological Treatment Market Share by Players (2020-2025)
Table 18. Global Top Overactive Bladder Non-Pharmacological Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Overactive Bladder Non-Pharmacological Treatment as of 2024)
Table 19. Ranking of Global Top Overactive Bladder Non-Pharmacological Treatment Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Overactive Bladder Non-Pharmacological Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Overactive Bladder Non-Pharmacological Treatment, Headquarters and Area Served
Table 22. Global Key Players of Overactive Bladder Non-Pharmacological Treatment, Product and Application
Table 23. Global Key Players of Overactive Bladder Non-Pharmacological Treatment, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Overactive Bladder Non-Pharmacological Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Overactive Bladder Non-Pharmacological Treatment Revenue Market Share by Type (2020-2025)
Table 27. Global Overactive Bladder Non-Pharmacological Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Overactive Bladder Non-Pharmacological Treatment Revenue Market Share by Type (2026-2031)
Table 29. Global Overactive Bladder Non-Pharmacological Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Overactive Bladder Non-Pharmacological Treatment Revenue Market Share by Application (2020-2025)
Table 31. Global Overactive Bladder Non-Pharmacological Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Overactive Bladder Non-Pharmacological Treatment Revenue Market Share by Application (2026-2031)
Table 33. North America Overactive Bladder Non-Pharmacological Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Overactive Bladder Non-Pharmacological Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Overactive Bladder Non-Pharmacological Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Overactive Bladder Non-Pharmacological Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Overactive Bladder Non-Pharmacological Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Overactive Bladder Non-Pharmacological Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Overactive Bladder Non-Pharmacological Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Overactive Bladder Non-Pharmacological Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Overactive Bladder Non-Pharmacological Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Overactive Bladder Non-Pharmacological Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Overactive Bladder Non-Pharmacological Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Overactive Bladder Non-Pharmacological Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Overactive Bladder Non-Pharmacological Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Overactive Bladder Non-Pharmacological Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Overactive Bladder Non-Pharmacological Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 48. Medtronic Company Details
Table 49. Medtronic Business Overview
Table 50. Medtronic Overactive Bladder Non-Pharmacological Treatment Product
Table 51. Medtronic Revenue in Overactive Bladder Non-Pharmacological Treatment Business (2020-2025) & (US$ Million)
Table 52. Medtronic Recent Development
Table 53. Axonics Modulation Technologies Company Details
Table 54. Axonics Modulation Technologies Business Overview
Table 55. Axonics Modulation Technologies Overactive Bladder Non-Pharmacological Treatment Product
Table 56. Axonics Modulation Technologies Revenue in Overactive Bladder Non-Pharmacological Treatment Business (2020-2025) & (US$ Million)
Table 57. Axonics Modulation Technologies Recent Development
Table 58. Cogentix Medica Company Details
Table 59. Cogentix Medica Business Overview
Table 60. Cogentix Medica Overactive Bladder Non-Pharmacological Treatment Product
Table 61. Cogentix Medica Revenue in Overactive Bladder Non-Pharmacological Treatment Business (2020-2025) & (US$ Million)
Table 62. Cogentix Medica Recent Development
Table 63. Laborie Medical Technologies Company Details
Table 64. Laborie Medical Technologies Business Overview
Table 65. Laborie Medical Technologies Overactive Bladder Non-Pharmacological Treatment Product
Table 66. Laborie Medical Technologies Revenue in Overactive Bladder Non-Pharmacological Treatment Business (2020-2025) & (US$ Million)
Table 67. Laborie Medical Technologies Recent Development
Table 68. Avation Medical Company Details
Table 69. Avation Medical Business Overview
Table 70. Avation Medical Overactive Bladder Non-Pharmacological Treatment Product
Table 71. Avation Medical Revenue in Overactive Bladder Non-Pharmacological Treatment Business (2020-2025) & (US$ Million)
Table 72. Avation Medical Recent Development
Table 73. Bioness Company Details
Table 74. Bioness Business Overview
Table 75. Bioness Overactive Bladder Non-Pharmacological Treatment Product
Table 76. Bioness Revenue in Overactive Bladder Non-Pharmacological Treatment Business (2020-2025) & (US$ Million)
Table 77. Bioness Recent Development
Table 78. Boston Scientific Company Details
Table 79. Boston Scientific Business Overview
Table 80. Boston Scientific Overactive Bladder Non-Pharmacological Treatment Product
Table 81. Boston Scientific Revenue in Overactive Bladder Non-Pharmacological Treatment Business (2020-2025) & (US$ Million)
Table 82. Boston Scientific Recent Development
Table 83. Allergan Company Details
Table 84. Allergan Business Overview
Table 85. Allergan Overactive Bladder Non-Pharmacological Treatment Product
Table 86. Allergan Revenue in Overactive Bladder Non-Pharmacological Treatment Business (2020-2025) & (US$ Million)
Table 87. Allergan Recent Development
Table 88. Abbvie Company Details
Table 89. Abbvie Business Overview
Table 90. Abbvie Overactive Bladder Non-Pharmacological Treatment Product
Table 91. Abbvie Revenue in Overactive Bladder Non-Pharmacological Treatment Business (2020-2025) & (US$ Million)
Table 92. Abbvie Recent Development
Table 93. Mindray Company Details
Table 94. Mindray Business Overview
Table 95. Mindray Overactive Bladder Non-Pharmacological Treatment Product
Table 96. Mindray Revenue in Overactive Bladder Non-Pharmacological Treatment Business (2020-2025) & (US$ Million)
Table 97. Mindray Recent Development
Table 98. APT Medical Company Details
Table 99. APT Medical Business Overview
Table 100. APT Medical Overactive Bladder Non-Pharmacological Treatment Product
Table 101. APT Medical Revenue in Overactive Bladder Non-Pharmacological Treatment Business (2020-2025) & (US$ Million)
Table 102. APT Medical Recent Development
Table 103. Vishee Company Details
Table 104. Vishee Business Overview
Table 105. Vishee Overactive Bladder Non-Pharmacological Treatment Product
Table 106. Vishee Revenue in Overactive Bladder Non-Pharmacological Treatment Business (2020-2025) & (US$ Million)
Table 107. Vishee Recent Development
Table 108. Beijing Easymonitor Technology Company Details
Table 109. Beijing Easymonitor Technology Business Overview
Table 110. Beijing Easymonitor Technology Overactive Bladder Non-Pharmacological Treatment Product
Table 111. Beijing Easymonitor Technology Revenue in Overactive Bladder Non-Pharmacological Treatment Business (2020-2025) & (US$ Million)
Table 112. Beijing Easymonitor Technology Recent Development
Table 113. NCC Medical Company Details
Table 114. NCC Medical Business Overview
Table 115. NCC Medical Overactive Bladder Non-Pharmacological Treatment Product
Table 116. NCC Medical Revenue in Overactive Bladder Non-Pharmacological Treatment Business (2020-2025) & (US$ Million)
Table 117. NCC Medical Recent Development
Table 118. Hangzhou General Stim Biotechnology Company Details
Table 119. Hangzhou General Stim Biotechnology Business Overview
Table 120. Hangzhou General Stim Biotechnology Overactive Bladder Non-Pharmacological Treatment Product
Table 121. Hangzhou General Stim Biotechnology Revenue in Overactive Bladder Non-Pharmacological Treatment Business (2020-2025) & (US$ Million)
Table 122. Hangzhou General Stim Biotechnology Recent Development
Table 123. Jiangsu Hengrui Pharmaceuticals Company Details
Table 124. Jiangsu Hengrui Pharmaceuticals Business Overview
Table 125. Jiangsu Hengrui Pharmaceuticals Overactive Bladder Non-Pharmacological Treatment Product
Table 126. Jiangsu Hengrui Pharmaceuticals Revenue in Overactive Bladder Non-Pharmacological Treatment Business (2020-2025) & (US$ Million)
Table 127. Jiangsu Hengrui Pharmaceuticals Recent Development
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report


List of Figures
Figure 1. Overactive Bladder Non-Pharmacological Treatment Picture
Figure 2. Global Overactive Bladder Non-Pharmacological Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Overactive Bladder Non-Pharmacological Treatment Market Share by Type: 2024 VS 2031
Figure 4. Behavior Therapy Features
Figure 5. Physical Training Features
Figure 6. Neuromodulation Methods Features
Figure 7. Others Features
Figure 8. Global Overactive Bladder Non-Pharmacological Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Overactive Bladder Non-Pharmacological Treatment Market Share by Application: 2024 VS 2031
Figure 10. Hospital Case Studies
Figure 11. Clinic Case Studies
Figure 12. Rehabilitation Institutions Case Studies
Figure 13. Others Case Studies
Figure 14. Overactive Bladder Non-Pharmacological Treatment Report Years Considered
Figure 15. Global Overactive Bladder Non-Pharmacological Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Overactive Bladder Non-Pharmacological Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Overactive Bladder Non-Pharmacological Treatment Market Share by Region: 2024 VS 2031
Figure 18. Global Overactive Bladder Non-Pharmacological Treatment Market Share by Players in 2024
Figure 19. Global Overactive Bladder Non-Pharmacological Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 20. The Top 10 and 5 Players Market Share by Overactive Bladder Non-Pharmacological Treatment Revenue in 2024
Figure 21. North America Overactive Bladder Non-Pharmacological Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Overactive Bladder Non-Pharmacological Treatment Market Share by Country (2020-2031)
Figure 23. United States Overactive Bladder Non-Pharmacological Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Overactive Bladder Non-Pharmacological Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Overactive Bladder Non-Pharmacological Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Overactive Bladder Non-Pharmacological Treatment Market Share by Country (2020-2031)
Figure 27. Germany Overactive Bladder Non-Pharmacological Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Overactive Bladder Non-Pharmacological Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Overactive Bladder Non-Pharmacological Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Overactive Bladder Non-Pharmacological Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Overactive Bladder Non-Pharmacological Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Overactive Bladder Non-Pharmacological Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Overactive Bladder Non-Pharmacological Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Overactive Bladder Non-Pharmacological Treatment Market Share by Region (2020-2031)
Figure 35. China Overactive Bladder Non-Pharmacological Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Overactive Bladder Non-Pharmacological Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Overactive Bladder Non-Pharmacological Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Overactive Bladder Non-Pharmacological Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Overactive Bladder Non-Pharmacological Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Overactive Bladder Non-Pharmacological Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Overactive Bladder Non-Pharmacological Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Overactive Bladder Non-Pharmacological Treatment Market Share by Country (2020-2031)
Figure 43. Mexico Overactive Bladder Non-Pharmacological Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Overactive Bladder Non-Pharmacological Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Overactive Bladder Non-Pharmacological Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Overactive Bladder Non-Pharmacological Treatment Market Share by Country (2020-2031)
Figure 47. Turkey Overactive Bladder Non-Pharmacological Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Overactive Bladder Non-Pharmacological Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Overactive Bladder Non-Pharmacological Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Medtronic Revenue Growth Rate in Overactive Bladder Non-Pharmacological Treatment Business (2020-2025)
Figure 51. Axonics Modulation Technologies Revenue Growth Rate in Overactive Bladder Non-Pharmacological Treatment Business (2020-2025)
Figure 52. Cogentix Medica Revenue Growth Rate in Overactive Bladder Non-Pharmacological Treatment Business (2020-2025)
Figure 53. Laborie Medical Technologies Revenue Growth Rate in Overactive Bladder Non-Pharmacological Treatment Business (2020-2025)
Figure 54. Avation Medical Revenue Growth Rate in Overactive Bladder Non-Pharmacological Treatment Business (2020-2025)
Figure 55. Bioness Revenue Growth Rate in Overactive Bladder Non-Pharmacological Treatment Business (2020-2025)
Figure 56. Boston Scientific Revenue Growth Rate in Overactive Bladder Non-Pharmacological Treatment Business (2020-2025)
Figure 57. Allergan Revenue Growth Rate in Overactive Bladder Non-Pharmacological Treatment Business (2020-2025)
Figure 58. Abbvie Revenue Growth Rate in Overactive Bladder Non-Pharmacological Treatment Business (2020-2025)
Figure 59. Mindray Revenue Growth Rate in Overactive Bladder Non-Pharmacological Treatment Business (2020-2025)
Figure 60. APT Medical Revenue Growth Rate in Overactive Bladder Non-Pharmacological Treatment Business (2020-2025)
Figure 61. Vishee Revenue Growth Rate in Overactive Bladder Non-Pharmacological Treatment Business (2020-2025)
Figure 62. Beijing Easymonitor Technology Revenue Growth Rate in Overactive Bladder Non-Pharmacological Treatment Business (2020-2025)
Figure 63. NCC Medical Revenue Growth Rate in Overactive Bladder Non-Pharmacological Treatment Business (2020-2025)
Figure 64. Hangzhou General Stim Biotechnology Revenue Growth Rate in Overactive Bladder Non-Pharmacological Treatment Business (2020-2025)
Figure 65. Jiangsu Hengrui Pharmaceuticals Revenue Growth Rate in Overactive Bladder Non-Pharmacological Treatment Business (2020-2025)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock